NYSE · Stocky rates: Cautious

Amrize Ltd (AMRZ)

$52.88 ▲ +1.99% as of 6 Aug, 07:50
54
/ 100
Neutral

What Stocky thinks

Cautious. AMRZ scores below-median on growth (45) and value (39) metrics, with a maxed-out Vulnerability Index indicating significant structural or competitive headwinds not yet fully priced in. Leadership Alignment at 61 is middling—insufficient conviction to offset operational risks. Fair valuation (17.7× forward P/E) alone doesn't justify entry without clearer evidence of margin recovery or competitive stabilization.

Compounder Score
45/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
61/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
39/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Amrize Ltd:

54
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 54/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

61
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Amrize Ltd (AMRZ) — frequently asked

Is Amrize Ltd (AMRZ) a good investment right now?

Stocky rates Amrize Ltd (AMRZ) at 54/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. AMRZ scores below-median on growth (45) and value (39) metrics, with a maxed-out Vulnerability Index indicating significant structural or competitive headwinds not yet fully priced in. Leadership Alignment at 61 is middling—insuff

What is AMRZ's Stocky Verdict?

AMRZ's current Stocky Verdict is 54/100, placing it in the "Cautious" band. This composite combines a 45/100 Compounder score, 61/100 Leadership, Moat rating, and analyst signal.

Does Amrize Ltd have a competitive moat?

Stocky hasn't finalised a Moat Score for Amrize Ltd yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Amrize Ltd's leadership aligned with shareholders?

Amrize Ltd scores 61/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to AMRZ?

Amrize Ltd's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Amrize Ltd.

This is just the surface. See the whole picture on Amrize Ltd.

Sign up free and unlock the full analysis on AMRZ — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering AMRZ — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for AMRZ.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how AMRZ changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to AMRZ?" · "Is AMRZ overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
54
/ 100 · Neutral

Or jump straight to the interactive dashboard for AMRZ in the app.